Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change Price Change
grade B 1.07 0.94% 0.01
ACST closed up 0.94 percent on Tuesday, March 19, 2019, on 82 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ACST trend table...

Date Alert Name Type % Chg
Mar 19 MACD Bullish Signal Line Cross Bullish 0.00%
Mar 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 19 Bollinger Band Squeeze Range Contraction 0.00%
Mar 19 NR7 Range Contraction 0.00%
Mar 18 MACD Bearish Signal Line Cross Bearish 0.94%
Mar 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.94%
Mar 18 Bollinger Band Squeeze Range Contraction 0.94%
Mar 18 BB Squeeze Started Range Contraction 0.94%
Mar 15 MACD Bullish Signal Line Cross Bullish 0.00%
Mar 15 180 Bullish Setup Bullish Swing Setup 0.00%

Older signals for ACST ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Medicine Chemistry Health Biopharmaceutical Cardiovascular Disease Lipid Cardiovascular Disorders Dietary Management Fatty Acids Hypertriglyceridemia Omega 3 Fatty Acid
Is ACST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.8
52 Week Low 0.43
Average Volume 349,241
200-Day Moving Average 0.8117
50-Day Moving Average 1.0338
20-Day Moving Average 1.0465
10-Day Moving Average 1.049
Average True Range 0.0568
ADX 13.84
+DI 14.1977
-DI 11.4437
Chandelier Exit (Long, 3 ATRs ) 0.9496
Chandelier Exit (Short, 3 ATRs ) 1.0639999999999999
Upper Bollinger Band 1.129
Lower Bollinger Band 0.964
Percent B (%b) 0.64
BandWidth 15.766842
MACD Line 0.0186
MACD Signal Line 0.0185
MACD Histogram 0.0001
Fundamentals Value
Market Cap 15.74 Million
Num Shares 14.7 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -1.39
Price-to-Sales 0.00
Price-to-Book 1.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.12
Resistance 3 (R3) 1.11 1.10 1.11
Resistance 2 (R2) 1.10 1.09 1.10 1.10
Resistance 1 (R1) 1.08 1.08 1.09 1.09 1.10
Pivot Point 1.07 1.07 1.07 1.07 1.07
Support 1 (S1) 1.05 1.06 1.06 1.06 1.04
Support 2 (S2) 1.04 1.05 1.04 1.04
Support 3 (S3) 1.02 1.04 1.03
Support 4 (S4) 1.03